COG8 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.287400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.985000E-01
Normal-vs-Stage2
4.889000E-01
Normal-vs-Stage3
1.675350E-01
Normal-vs-Stage4
9.260000E-01
Stage1-vs-Stage2
4.715400E-01
Stage1-vs-Stage3
2.191600E-01
Stage1-vs-Stage4
4.178200E-01
Stage2-vs-Stage3
1.227410E-01
Stage2-vs-Stage4
3.622400E-01
Stage3-vs-Stage4
1.359770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.025200E-01
Normal-vs-AfricanAmerican
9.615800E-01
Normal-vs-Asian
4.677200E-01
Caucasian-vs-AfricanAmerican
3.185200E-01
Caucasian-vs-Asian
5.834400E-01
AfricanAmerican-vs-Asian
2.992800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.220600E-01
Normal-vs-Female
6.680400E-01
Male-vs-Female
1.785580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.131000E-01
Normal-vs-Age(41-60Yrs)
6.563000E-01
Normal-vs-Age(61-80Yrs)
4.809400E-01
Normal-vs-Age(81-100Yrs)
5.823000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.937800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.340000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.276800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.159430E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.698000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.169400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.670600E-01
Normal-vs-Daily Drinker
2.414000E-01
Normal-vs-Weekly Drinker
2.446400E-01
Normal-vs-Occasional Drinker
9.457200E-01
Normal-vs-Social Drinker
9.861800E-01
Non Drinker-vs-Daily Drinker
7.974800E-01
Non Drinker-vs-Weekly Drinker
7.376800E-01
Non Drinker-vs-Occasional Drinker
3.828400E-02
Non Drinker-vs-Social Drinker
5.469700E-02
Daily Drinker-vs-Weekly Drinker
9.163200E-01
Daily Drinker-vs-Occasional Drinker
3.855900E-02
Daily Drinker-vs-Social Drinker
5.015900E-02
Weekly Drinker-vs-Occasional Drinker
6.330500E-02
Weekly Drinker-vs-Social Drinker
7.119800E-02
Occasional Drinker-vs-Social Drinker
8.789800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.048960E-01
Normal-vs-Grade 2
4.510800E-01
Normal-vs-Grade 3
4.364300E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.272800E-01
Grade 1-vs-Grade 3
1.043750E-02
Grade 1-vs-Grade 4
1.048960E-01
Grade 2-vs-Grade 3
1.065640E-02
Grade 2-vs-Grade 4
4.510800E-01
Grade 3-vs-Grade 4
4.364300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.347400E-01
Normal-vs-NonDiabetic
6.016000E-01
Diabetic-vs-NonDiabetic
4.541800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.897800E-01
Normal-vs-NoPancreatitis
4.853600E-01
Pancreatitis-vs-NoPancreatitis
4.861800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.625200E-01
Normal-vs-N1
4.711800E-01
N0-vs-N1
1.467040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.729000E-01
Normal-vs-TP53-NonMutant
6.778600E-01
TP53-Mutant-vs-TP53-NonMutant
3.169000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
